Cochrane: C for Cancel? - Part 5

Where's the update and the new review, as promised?

In our Part 3 on the BMJ EBM analysis article, we reported how the Cochrane HPV review missed eligible trials, as well as reporting bias, biased trial designs, and conflicts of interest. If that wasn’t enough, the authors planned unpublished data requests didn’t happen.

Cochrane: C for Cancel - Part 3

We now get to the issue of what surprised even the TTE office.

The Cochrane systematic review of human papillomavirus (HPV) vaccine was published on May 9 2018. The article, ‘The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias’ was submitted to BMJ EBM on May 24 2018, was sent for peer review and then accepted after changes for publication online on July 27 2018.

Cochrane launched an investigation following criticism and published their response on September 3, authored by Editor in Chief David Tovey and Deputy Editor in Chief Karla Soares-Weiser, supporting the Cochrane HPV Review.

In just over five weeks, the Cochrane hierarchy responded with a 30-page criticism that defended their revie…